Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Use of an automated clinical management system improves outpatient immunosuppressive care following liver transplantation.

Park ES, Peccoud MR, Wicks KA, Halldorson JB, Carithers RL Jr, Reyes JD, Perkins JD.

J Am Med Inform Assoc. 2010 Jul-Aug;17(4):396-402. doi: 10.1136/jamia.2009.000992.

2.
3.

Mycophenolate mofetil in pancreas transplantation.

Gruessner RW, Sutherland DE, Drangstveit MB, Wrenshall L, Humar A, Gruessner AC.

Transplantation. 1998 Aug 15;66(3):318-23.

PMID:
9721799
4.

Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2005 May;9(21):1-179, iii-iv. Review.

5.

The cost effectiveness of tacrolimus versus microemulsified cyclosporin: a 10-year model of renal transplantation outcomes.

Orme ME, Jurewicz WA, Kumar N, McKechnie TL.

Pharmacoeconomics. 2003;21(17):1263-76.

PMID:
14986738
6.

Tacrolimus: a further update of its use in the management of organ transplantation.

Scott LJ, McKeage K, Keam SJ, Plosker GL.

Drugs. 2003;63(12):1247-97. Review.

PMID:
12790696
7.

A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.

Yao G, Albon E, Adi Y, Milford D, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2006 Dec;10(49):iii-iv, ix-xi, 1-157. Review.

8.

Status of liver and gastrointestinal transplantation at the University of Miami.

Weppler D, Khan R, Fragulidis GP, Nery JR, Ricordi C, Tzakis AG.

Clin Transpl. 1996:187-201.

PMID:
9286568
9.

A novel management strategy of steroid-free immunosuppression after liver transplantation: efficacy and safety of tacrolimus and mycophenolate mofetil.

Ringe B, Braun F, Schütz E, Füzesi L, Lorf T, Canelo R, Oellerich M, Ramadori G.

Transplantation. 2001 Feb 27;71(4):508-15.

PMID:
11258429
10.

Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.

Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.

Transpl Immunol. 2008 Nov;20(1-2):32-42. doi: 10.1016/j.trim.2008.08.005. Epub 2008 Sep 4.

PMID:
18773960
11.

Outcomes in African American kidney transplant patients receiving tacrolimus and mycophenolic acid immunosuppression.

Narayanan M, Pankewycz O, El-Ghoroury M, Shihab F, Wiland A, McCague K, Chan L.

Transplantation. 2013 Feb 27;95(4):566-72. doi: 10.1097/TP.0b013e318277438f.

PMID:
23423268
12.
13.

Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.

Stegall MD, Wachs ME, Everson G, Steinberg T, Bilir B, Shrestha R, Karrer F, Kam I.

Transplantation. 1997 Dec 27;64(12):1755-60.

PMID:
9422416
14.

An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence.

Venkat VL, Nick TG, Wang Y, Bucuvalas JC.

Pediatr Transplant. 2008 Feb;12(1):67-72. doi: 10.1111/j.1399-3046.2007.00794.x.

PMID:
18186891
15.
16.

FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.

Woodle ES, Bruce DS, Josephson M, Newell KA, Piper JB, Millis JM, Cronin D, Whitman G, Ruebe M, Thistlethwaite JR Jr.

Clin Transplant. 1996 Aug;10(4):323-32.

PMID:
8884103
17.

Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months.

Ramirez CB, Doria C, di Francesco F, Iaria M, Kang Y, Marino IR.

J Surg Res. 2007 Apr;138(2):198-204. Epub 2007 Feb 8.

PMID:
17292404
19.

Tacrolimus (FK506) and mycophenolate mofetil combination therapy versus tacrolimus in adult liver transplantation.

Eckhoff DE, McGuire BM, Frenette LR, Contreras JL, Hudson SL, Bynon JS.

Transplantation. 1998 Jan 27;65(2):180-7.

PMID:
9458011
20.

A randomized, prospective, pharmacoeconomic trial of neoral 2-hour postdose concentration monitoring versus tacrolimus trough concentration monitoring in de novo liver transplant recipients.

Shenoy S, Hardinger KL, Crippin J, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W.

Liver Transpl. 2008 Feb;14(2):173-80. doi: 10.1002/lt.21355.

Items per page

Supplemental Content

Write to the Help Desk